Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related macular degeneration (AMD). Their findings, published in Genome Medicine, could help inform future efforts to develop more targeted treatments for people at greatest risk of developing severe macular degeneration and losing their sight.